Cole Harris Sterling, MD

Dr. Joon Kang focuses on the diagnosis and treatment of seizures and epilepsy. Dr. Kang has a clinical interest in the pre-surgical evaluation and treatment of patients who have drug resistant epilepsy. Her research interests include minimally invasive epilepsy surgery, continuous electroencephalogram (EEG) monitoring in the intensive care unit (ICU) and status epilepticus.Dr. Kang received her bachelor degree from University of Pennsylvania and went on to receive her medical degree from Drexel College of Medicine. After internship at Pennsylvania Hospital, she completed residency and fellowship training in clinical neurophysiology and epilepsy at Thomas Jefferson University Hospital in Philadelphia, PA.Dr. Kang currently sees patients at The Johns Hopkins outpatient center on Monday and Wednesday afternoons.

Dr. Ronald Sherman is the podiatric surgeon in the Division of Vascular Surgery and Endovascular Therapy at Johns Hopkins Hospital. He graduated from the New York College of Podiatric Medicine and completed his surgical training at Lutheran Hospital in Baltimore. He has served as a Residency Director in podiatric surgery for over a decade at both University of Maryland Medical System and Mercy Medical Center, having graduated more than thirty podiatric physicians. With over thirty-five years of experience, he has developed an expertise in the care of the diabetic foot wound and the lower extremity. Dr. Sherman has been contributing to the Johns Hopkins Multidisciplinary Diabetic Foot and Wound Clinic as a principle clinician since 2012 focusing on healing unresponsive foot ulcerations and reconstruction of diabetic wounds.His research interest involves regenerative medicine employing innovative biologics, utilization of immunologically privileged wound modalities and computerized gait analysis of the diabetic foot towards reducing foot ulceration and hence preserving the lower extremity.

Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins.Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy.